4) Secondary prevention of heart disease

Capricorn Investigators, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. The Lancet. ,vol. 357, pp. 1385- 1390 ,(2001) , 10.1016/S0140-6736(00)04560-8

Salim Yusuf, Richard Peto, John Lewis, Rory Collins, Peter Sleight, Beta blockade during and after myocardial infarction: An overview of the randomized trials Progress in Cardiovascular Diseases. ,vol. 27, pp. 335- 371 ,(1985) , 10.1016/S0033-0620(85)80003-7

John C. LaRosa, Jiang He, Suma Vupputuri, Effect of Statins on Risk of Coronary Disease JAMA. ,vol. 282, pp. 2340- 2346 ,(1999) , 10.1001/JAMA.282.24.2340

Ida Sim, Kathryn M. McDonald, Philip W. Lavori, Catherine M. Norbutas, Mark A. Hlatky, Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death Circulation. ,vol. 96, pp. 2823- 2829 ,(1997) , 10.1161/01.CIR.96.9.2823

Marcus D Flather, Salim Yusuf, Lars Køber, Marc Pfeffer, Alistair Hall, Gordon Murray, Christian Torp-Pedersen, Stephen Ball, Janice Pogue, Lemuel Moyé, Eugene Braunwald, Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients The Lancet. ,vol. 355, pp. 1575- 1581 ,(2000) , 10.1016/S0140-6736(00)02212-1

Klas Malmberg, Anna Norhammar, Hans Wedel, Lars Rydén, Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study Circulation. ,vol. 99, pp. 2626- 2632 ,(1999) , 10.1161/01.CIR.99.20.2626